Combination of APG-2575, Olverembatinib (HQP1351), Liposome Mitoxantrone and Homoharringtonine(MHO2575) in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 0a28cac8a3cb6bee90bc23971473ec758c9b86cc
First added on: Oct 10, 2026